Encapsulation of chimeric protein rSAG1/2 into poly(lactide-co-glycolide) microparticles induces long-term protective immunity against Toxoplasma gondii in mice-Reference-Cited by-同舟云学术

Encapsulation of chimeric protein rSAG1/2 into poly(lactide-co-glycolide) microparticles induces long-term protective immunity against Toxoplasma gondii in mice

Published:2013-08 Issue:4 Volume:134 Page:430-437
ISSN:0014-4894
Container-title:Experimental Parasitology
language:en
Short-container-title:Experimental Parasitology

Author:

Chuang Shu-Chun,Ko Jing-Chun,Chen Chaio-Ping,Du Jia-Tze,Yang Chung-Da

Publisher

Elsevier BV

Subject

Immunology,General Medicine,Parasitology,Infectious Diseases

Reference25 articles.

1. Development of a vaccine for toxoplasmosis: current status;Bhopale;Microbes Infect.,2003

2. Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(DL-lactide-co-glycolide) microspheres;Byrd;Vaccine,2006

3. Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles;Chuang;Parasit. Vectors,2013

4. Surface antigens of Toxoplasma gondii;Couvreur;Parasitology,1988

5. Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion;Grimwood;Int. J. Parasitol.,1996

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines;BioDrugs;2023-01-06

2. PLGA Nanoparticles as an Efficient Platform in Protein Vaccines Against Toxoplasma gondii;Acta Parasitologica;2022-01-11

3. Co-delivery of PLGA nanoparticles loaded with rSAG1 antigen and TLR ligands: An efficient vaccine against chronic toxoplasmosis;Microbial Pathogenesis;2022-01

4. Immunogenicity and Protective Effect of a Virus-Like Particle Containing the SAG1 Antigen of Toxoplasma gondii as a Potential Vaccine Candidate for Toxoplasmosis;Biomedicines;2020-04-18

5. Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review;Comparative Immunology, Microbiology and Infectious Diseases;2020-04